Antecubital IVs are uncomfortable and risky . Given staph aureus bacteremia comes with a 20% 30-day mortality, everything we can do to mitigate this risk helps! Stay away from “just-in-case” IV catheters.
BIG!!: PIVs: AC site = high-risk for S.A. bacteremia esp Emergently placed. (OR ~12). Risk soars ≥4 days to 50x risk. Prefer forearm/hand. Remove early if possible. Make a Nsg Policy. Know where your lines are. @UAMSInfDisease@ryankdare@uamshealth@UAMS#MedEd #InfectionPrevention
Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial
✅ Just Accepted
⭐ Editor's Choice
🔗 https://t.co/301v0rS2TL
So excited to have our Keynote Speaker for this year's Symposium: Dr. Katherine Lusardi! Her keynote lecture will be "Ready Steward One: Gamification of ID and Stewardship Education"
A bit late in posting, but here it is... Thanks to all my ID attendings @UAMSInfDisease@MichaelSaccent2#IDTwitter
Dr. Sanikommu,
We are happy to announce that we will be inviting you to present a poster during the “Interesting Cases Submitted During the IDWeek Call for Cases”
One love to @UAMSInfDisease for helping me grow 💕 over the last 2 yrs. It's been a pleasure working with you all 🙏, had an exceptional fellowship experience! It was fun graduating and excited to fly solo #IDTwitter
Here's a summary of the new CDC Clinical Guidelines on the use of doxycycline post-exposure prophylaxis for bacterial sexually transmitted infection prevention.
Incredible IM grand rounds with Dr. Wohl @DavidAlainWohl , Professor of Medicine, Infectious Diseases, University of North Carolina!! Fellows had a fantastic one-on-one interactive session, and we greatly appreciated your talk on "Overcoming Barriers to PrEP Uptake." #IDtwitter
Following the trend of shorter is better, our ID pharmacist, Alina Viteri, discusses long vs short duration of therapy in pseudomonas and cdiff infections! This is a tricky one , we appreciate the great presentation and will look forward to more studies on these #idtwitter